CLINICAL_TRIALS
trial_result
· 2022-06-23
Clinical Trial Update: Chronic Pain Master Protocol (CPMP): A Study of LY3016859 in Participants With Osteoarthritis [Phase 2]
Summary
Phase 2 study of LY3016859 in osteoarthritis completed; results posted in 2022.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Osteoarthritis | Phase 2 | Status: COMPLETED | Results posted: 2022-06-23